<DOC>
	<DOCNO>NCT00315601</DOCNO>
	<brief_summary>The major objective research see much , long , telithromycin azithromycin get fluid cell lung .</brief_summary>
	<brief_title>Intrapulmonary Pharmacokinetics Antibiotics</brief_title>
	<detailed_description>The primary objective descriptive study determine compare plasma , epithelial lining fluid ( ELF ) , alveolar macrophage ( AM ) concentration follow multiple oral dos telithromycin azithromycin healthy , non-smoking adult subject .</detailed_description>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Between 18 55 year , inclusive , age No history smoking within last 1 year Body weight within +/ 15 % Metropolitan Life Insurance Company table No clinically important abnormality medical history physical exam Female subject childbearing potential must negative pregnancy test Female subject childbearing potential must use reliable method birth control Allergy telithromycin , azithromycin , macrolide antibiotic Allergy serious adverse reaction benzodiazepine lidocaine History renal , gastrointestinal , liver disease Significant hypertension Clinically significant heart pulmonary disease History drug alcohol dependence within 12 month study entry Positive pregnancy test Currently breast feed Use drug within 2 week study entry Received investigational drug within 30 day study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Telithromycin ( drug )</keyword>
	<keyword>Azithromycin ( drug )</keyword>
	<keyword>Bronchoalveolar lavage ( procedure )</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>